Science Explorer Interactive view Map
Topic · Cell Biology

Myofascial pain diagnosis and treatment

Myofascial pain diagnosis and treatment is a research topic within Cell Biology. Science Explorer counts 19k research works in it since 1950. 11.4% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the biochemical milieu, diagnosis, management, and treatment of myofascial pain syndrome, with an emphasis on myofascial trigger points, dry needling, fascial plasticity, and the use of ultrasound technology. It also explores the role of botulinum toxin, connective tissue, and neurobiological explanations in understanding and addressing myofascial pain.

  • Myofascial Trigger Points
  • Pain Management
  • Dry Needling
  • Fascial Plasticity
  • Muscle Pain Syndrome
  • Ultrasound Technology
  • Botulinum Toxin
  • Connective Tissue
  • Neurobiological Explanation
  • Physical Therapies
Research works
19k
fractional, since 1950
In the world top 10%
2.2k
per year above
Top-10% rate
11.4%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+40%
the tick is no change

Which countries lead Myofascial pain diagnosis and treatment research?

By volume, the United States and China publish the most (637 and 454 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 637 works
  2. 2 China 454 works
  3. 3 India 313 works
  4. 4 Türkiye 244 works
  5. 5 Russia 224 works
  6. 6 Germany 169 works
  7. 7 Spain 162 works
  8. 8 South Korea 137 works
  9. 9 Brazil 126 works
  10. 10 Pakistan 124 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 24.6%China: 17.5%India: 12.1%Türkiye: 9.4%6 others listed: 36.4%25%largest
United States637 · 24.6%China454 · 17.5%India313 · 12.1%Türkiye244 · 9.4%6 others listed943 · 36.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Myofascial pain diagnosis and treatment research?

By volume in 2022–2025, Cairo University publishes the most Myofascial pain diagnosis and treatment research, followed by Sechenov University and Sağlık Bilimleri Üniversitesi.

Who are the leading researchers in Myofascial pain diagnosis and treatment?

The most-cited researchers publishing on Myofascial pain diagnosis and treatment include Rachelle Buchbinder.

  1. 1 Rachelle Buchbinder Australia 3.5k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Myofascial pain diagnosis and treatment research done?

The largest centres of Myofascial pain diagnosis and treatment research in 2022–2025 are Moscow (Russia), Beijing (China), Istanbul (Türkiye) and Seoul (South Korea). Among places with at least 20 works in it, it is an unusually large share of all research in Kansas City, Rawalpindi and Giza.

Largest cities, 2022–2025

  1. 1 Moscow Russia 101 works
  2. 2 Beijing China 78 works
  3. 3 Istanbul Türkiye 76 works
  4. 4 Seoul South Korea 62 works
  5. 5 Tehran Iran 60 works
  6. 6 Shanghai China 48 works
  7. 7 Madrid Spain 45 works
  8. 8 Giza Egypt 41 works
  9. 9 Ankara Türkiye 40 works
  10. 10 Lahore Pakistan 36 works

Where it is the local speciality

  1. Kansas CityUS · 24.1 works20×
  2. RawalpindiPK · 21.8 works8.6×
  3. GizaEG · 40.9 works6.8×
← less than its size predictsmore →

Location quotient: how much more of its research is in Myofascial pain diagnosis and treatment than the world average.

See Myofascial pain diagnosis and treatment on the map

Where is the best place to study Myofascial pain diagnosis and treatment?

Among universities, judged by research, Cairo University, Sechenov University and Istanbul Medipol University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 12.21%fractional works in this node (log) →share in the world top 10% →Cairo University: 36, 3.3%Sechenov University: 27, 4.3%Istanbul Medipol University: 9, 25.7%University of Padua: 14, 38.2%Iran University of Medical Sciences: 13, 5.3%University of Lahore: 15, 7.7%Shanghai University of Traditional Chinese Medicine: 9, 20.9%Datta Meghe Institute of Higher Education and Research: 13, 10.3%Riphah International University: 16, 1.4%Tehran University of Medical Sciences: 16, 5.0%University of PaduaIstanbul Medipol Uni…Sechenov UniversityCairo University
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Cairo UniversityEgypt 66.53.3%11.5×36 +355.5%
2 Sechenov UniversityRussia 62.84.3%21.7×27 +247.8%
3 Istanbul Medipol UniversityTürkiye 54.725.7%13.9×9
4 University of PaduaItaly 54.538.2%4.2×14 +32.4%
5 Iran University of Medical SciencesIran 53.55.3%12.3×13 +596.1%
6 University of LahorePakistan 51.27.7%20.4×15
7 Shanghai University of Traditional Chinese MedicineChina 46.920.9%11.7×9 +1.9%
8 Datta Meghe Institute of Higher Education and ResearchIndia 45.410.3%13.9×13
9 Riphah International UniversityPakistan 45.21.4%27.5×16 +28.2%
10 Tehran University of Medical SciencesIran 43.95.0%8.4×16 +80.1%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Myofascial pain diagnosis and treatment research growing?

Output in 2018–2022 was 40% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Myofascial pain diagnosis and treatment.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.